Best practices for estimating and reporting epidemiological delay distributions of infectious diseases using public health surveillance and healthcare data
Authors:
Kelly Charniga,
Sang Woo Park,
Andrei R Akhmetzhanov,
Anne Cori,
Jonathan Dushoff,
Sebastian Funk,
Katelyn M Gostic,
Natalie M Linton,
Adrian Lison,
Christopher E Overton,
Juliet R C Pulliam,
Thomas Ward,
Simon Cauchemez,
Sam Abbott
Abstract:
Epidemiological delays, such as incubation periods, serial intervals, and hospital lengths of stay, are among key quantities in infectious disease epidemiology that inform public health policy and clinical practice. This information is used to inform mathematical and statistical models, which in turn can inform control strategies. There are three main challenges that make delay distributions diffi…
▽ More
Epidemiological delays, such as incubation periods, serial intervals, and hospital lengths of stay, are among key quantities in infectious disease epidemiology that inform public health policy and clinical practice. This information is used to inform mathematical and statistical models, which in turn can inform control strategies. There are three main challenges that make delay distributions difficult to estimate. First, the data are commonly censored (e.g., symptom onset may only be reported by date instead of the exact time of day). Second, delays are often right truncated when being estimated in real time (not all events that have occurred have been observed yet). Third, during a rapidly growing or declining outbreak, overrepresentation or underrepresentation, respectively, of recently infected cases in the data can lead to bias in estimates. Studies that estimate delays rarely address all these factors and sometimes report several estimates using different combinations of adjustments, which can lead to conflicting answers and confusion about which estimates are most accurate. In this work, we formulate a checklist of best practices for estimating and reporting epidemiological delays with a focus on the incubation period and serial interval. We also propose strategies for handling common biases and identify areas where more work is needed. Our recommendations can help improve the robustness and utility of reported estimates and provide guidance for the evaluation of estimates for downstream use in transmission models or other analyses.
△ Less
Submitted 14 May, 2024;
originally announced May 2024.
Key Questions for Modelling COVID-19 Exit Strategies
Authors:
Robin N Thompson,
T Deirdre Hollingsworth,
Valerie Isham,
Daniel Arribas-Bel,
Ben Ashby,
Tom Britton,
Peter Challoner,
Lauren H K Chappell,
Hannah Clapham,
Nik J Cunniffe,
A Philip Dawid,
Christl A Donnelly,
Rosalind Eggo,
Sebastian Funk,
Nigel Gilbert,
Julia R Gog,
Paul Glendinning,
William S Hart,
Hans Heesterbeek,
Thomas House,
Matt Keeling,
Istvan Z Kiss,
Mirjam Kretzschmar,
Alun L Lloyd,
Emma S McBryde
, et al. (18 additional authors not shown)
Abstract:
Combinations of intense non-pharmaceutical interventions ('lockdowns') were introduced in countries worldwide to reduce SARS-CoV-2 transmission. Many governments have begun to implement lockdown exit strategies that allow restrictions to be relaxed while attempting to control the risk of a surge in cases. Mathematical modelling has played a central role in guiding interventions, but the challenge…
▽ More
Combinations of intense non-pharmaceutical interventions ('lockdowns') were introduced in countries worldwide to reduce SARS-CoV-2 transmission. Many governments have begun to implement lockdown exit strategies that allow restrictions to be relaxed while attempting to control the risk of a surge in cases. Mathematical modelling has played a central role in guiding interventions, but the challenge of designing optimal exit strategies in the face of ongoing transmission is unprecedented. Here, we report discussions from the Isaac Newton Institute 'Models for an exit strategy' workshop (11-15 May 2020). A diverse community of modellers who are providing evidence to governments worldwide were asked to identify the main questions that, if answered, will allow for more accurate predictions of the effects of different exit strategies. Based on these questions, we propose a roadmap to facilitate the development of reliable models to guide exit strategies. The roadmap requires a global collaborative effort from the scientific community and policy-makers, and is made up of three parts: i) improve estimation of key epidemiological parameters; ii) understand sources of heterogeneity in populations; iii) focus on requirements for data collection, particularly in Low-to-Middle-Income countries. This will provide important information for planning exit strategies that balance socio-economic benefits with public health.
△ Less
Submitted 21 July, 2020; v1 submitted 21 June, 2020;
originally announced June 2020.
